BBP-398 (Formerly known as IACS-15509)
Phase 1Terminated 0 watching 0 views this week๐ค Quiet
30
Development Stage
โ
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Tumor, Solid
Conditions
Tumor, Solid
Trial Timeline
Nov 12, 2020 โ Jul 30, 2024
NCT ID
NCT04528836About BBP-398 (Formerly known as IACS-15509)
BBP-398 (Formerly known as IACS-15509) is a phase 1 stage product being developed by BridgeBio Pharma for Tumor, Solid. The current trial status is terminated. This product is registered under clinical trial identifier NCT04528836. Target conditions include Tumor, Solid.
Hype Score Breakdown
Clinical
10
Activity
5
Company
7
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04528836 | Phase 1 | Terminated |
Competing Products
20 competing products in Tumor, Solid